Navellier & Associates »

Catalyst Pharmaceutical Partners shares owned by Navellier & Associates

Quarter-by-quarter ownership of Catalyst Pharmaceutical Partners (CPRX) shares owned by Navellier & Associates from 13F filings

Historical chart of Navellier & Associates investment in Catalyst Pharmaceutical Partners

Tip: Access up to 7 years of quarterly data

All positions including Catalyst Pharmaceutical Partners held by Navellier & Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Catalyst Pharmaceutical Partners by Navellier & Associates

Quarter filed Position value Share count Share price at filing
2023-12-31 $2.6M 154k 16.81
2023-09-30 $1.6M 137k 11.69
2023-06-30 $1.7M 125k 13.44
2023-03-31 $2.1M 125k 16.58
2022-12-31 $2.0M 110k 18.60
2022-09-30 $1.3M 105k 12.83

More positions owned by Navellier & Associates

NVIDIA Corporation (NVDA)
Exxon Mobil Corporation (XOM)
Quanta Services (PWR)
ConocoPhillips (COP)
Eli Lilly & Co. (LLY)
Microsoft Corporation (MSFT)
Apple (AAPL)
Novo Nordisk A/S (NVO)
Super Micro Computer (SMCI)
Phillips 66 (PSX)
EOG Resources (EOG)
Emcor (EME)
Valero Energy Corporation (VLO)
Costco Wholesale Corporation (COST)
Builders FirstSource (BLDR)

View all positions for Navellier & Associates

Top funds holding Catalyst Pharmaceutical Partners

Deerfield Management Company
Vanguard Group
Dimensional Fund Advisors
Royce & Associates
Robeco Investment Management
Jacobs Levy Equity Management
Opaleye Management
T. Rowe Price Associates
Henderson Group
Charles Schwab Investment Management
Goldman Sachs Group
LSV Asset Management
Jupiter Asset Management
Bank of New York Mellon
Bank of America Corporation

View all funds holding Catalyst Pharmaceutical Partners